Near-Field IR Microscope For Nanoscale Chemical Imaging
Project Number7R21EB003101-02
Former Number1R21CA104623-01
Contact PI/Project LeaderWALKER, GILBERT C
Awardee OrganizationUNIVERSITY OF TORONTO
Description
Abstract Text
DESCRIPTION (provided by applicant): The goal of this project is to develop an attachment for a scanning probe microscope that enables high throughput, apertureless, near field infrared microscopy (ANSIM). The development of this instrument will enable sensing applications that require the characterization of extremely small regions of complex biological materials on surfaces. The proposed near field instrument will be able to perform IR absorption spectroscopy at less than 100nm lateral spatial resolution. The ANSIM attachment will be designed to be small and portable, so that replicas of this attachment may become a practical add-on to other atomic force microscopes (AFMs). The instrument development program has three principal elements. First, infrared (IR) quantum cascade laser arrays will be assembled with the optics for guiding the IR laser light into and out of the microscope. Second, multi-channel detection and signal processing modules will be built and integrated with a common, commercial instrument. Third, improved designs of the sharp metal tip used in an apertureless near-field scanning infrared microscopes will be tested and optimized. IR spectroscopic chemical imaging of manmade polymeric surfaces at 100nm lateral resolution using apertureless near field microscopy has already been demonstrated in preliminary work. The goal of this exploratory proposal is to determine whether useful information can be acquired for imaging biological molecules, and whether technology that would be readily used by other scientists can be developed.
The test measurements will concentrate on imaging peptide layers and their secondary structure, primarily using IR active amide bands. This would be the first time IR near field microscopy has been applied to peptide and protein analysis, and would represent a significant step forward in biochemical imaging using scanning probe microscopy. Polyglutamine (PG) and its aggregates have been chosen for demonstration studies because 1) PG has a relatively simple IR spectrum related to its secondary structure and 2) PG structures have been implicated in diseases associated with the deposition of insoluble aggregations of proteins, known as fibrils, in various human organs. To treat or to prevent such diseases, improved ability to observe the formation and the deposition of such insoluble aggregates is required; IR near field microscopy could have considerable impact in this area.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
259999779
UEI
NBMSSFM3HP56
Project Start Date
01-April-2004
Project End Date
31-March-2007
Budget Start Date
01-April-2005
Budget End Date
31-March-2006
Project Funding Information for 2005
Total Funding
$131,456
Direct Costs
$125,000
Indirect Costs
$6,456
Year
Funding IC
FY Total Cost by IC
2005
National Institute of Biomedical Imaging and Bioengineering
$131,456
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7R21EB003101-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7R21EB003101-02
Patents
No Patents information available for 7R21EB003101-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7R21EB003101-02
Clinical Studies
No Clinical Studies information available for 7R21EB003101-02
News and More
Related News Releases
No news release information available for 7R21EB003101-02
History
No Historical information available for 7R21EB003101-02
Similar Projects
No Similar Projects information available for 7R21EB003101-02